If you’re unfamiliar with V2X, it was created through the July 5, 2022, reverse merger of publicly-traded Vectrus Inc. and privately-owned The Vertex Company. The combination created a company ...

RESTON, Va., April 3, 2025 /PRNewswire/ -- V2X, Inc., (NYSE: VVX), announces it has successfully repriced and extended its $238 million Term Loan A and $500 million Revolving Credit Facility ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Vertex Pharmaceuticals (VRTX – Research Report) and Apellis ...

Wells Fargo analyst Mohit Bansal maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report) yesterday and set a price target of $460.00. The company’s shares closed yesterday ...

We recently published a list of 8 Best Gene-Editing Stocks to Buy. In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against other best ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Creating a strong brand identity ...